Should we continue to offer consolidative radiation for early stage, non-bulky Hodgkin's disease for individuals who have had a complete response (Deauville 1 or 2) after chemotherapy by PET?

How have the results of the UK RAPID study (Radford et al NEJM 2015) changed your practice?

Answer from: Radiation Oncologist at Academic Institution

The RAPID study was a non-inferiority trial. This requires a small editorial. Non-inferiority trials are designed to test that one approach is "not worse" than an accepted standard. However, in essence you are testing that one approach is "not unacceptably worse" than an accepted standard, because t...

Comments

Radiation Oncologist at Community Hospital
@Christopher R. Kelsey, thank you for your very th...

Radiation Oncologist at Hospital of the University of Pennsylvania
@Christopher R. Kelsey had hit the nail on th...

Please select the option that best describes you:

Should we continue to offer consolidative radiation for early stage, non-bulky Hodgkin's disease for individuals who have had a complete response (Deauville 1 or 2) after chemotherapy by PET?

Related Questions